EUVIMEDEUVIMED entdecken
Crossref

Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic ductal adenocarcinoma

Kege Yang, Ziyi Zhong, Jinmao Zou, Jian-You Liao, Shaojie Chen, Shurui Zhou, Yue Zhao, Jiajia Li, Dong Yin, Kaihong Huang, Yaqing Li

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.216840 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Kege Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, PR China; Guangdong Provincial Key Laboratory of Ma…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Glycolysis, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal malignancies, highlighting the urgent need to elucidate the underlying oncogenic mechanisms. VIRMA is a classic isoform of methyltransferases that participates in epigenetic transcriptomic modification in eukaryotic mRNAs. However, the exact roles of VIRMA in PDAC remain unclear. Here, we identified that VIRMA is highly expressed in PDAC, and histone modifications of the promoter may partly account for this dysregulation. Moreover, VIRMA is closely related to glycolysis and poor prognosis in PDAC. We further determined that STRA6 is a direct downstream target of VIRMA in PDAC by RNA sequencing (RNA-seq) and m6A sequencing (m6A-seq). VIRMA is involved in gene expression regulation via 3' UTR targeting of STRA6 mRNA. Furthermore, the m6A reader IGF2BP2 was shown to critically contribute to the stability of STRA6 mRNA. We describe the role of VIRMA in promoting signaling via the STRA6/STAT3 axis, which results in increased levels of HIF-1α, a key activator of glycolysis. In vivo and in vitro experiments reveal that the VIRMA-STRA6-STAT3-HIF-1α axis plays an instrumental role in glycolysis and tumor progression in PDAC. In conclusion, we demonstrate that VIRMA can increase glycolysis in PDAC by upregulating STRA6, a cell surface membrane protein that stimulates the STAT3 pathway, thereby activating HIF-1α and leading to pancreatic cancer malignancy. Overall, our data strongly suggest that the VIRMA-STRA6-STAT3-HIF-1α axis is a viable therapeutic target in PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsGlycolysisGene Expression Regulation, NeoplasticUp-RegulationHumansCell Line, TumorAnimalsDisease ProgressionMethyltransferasesMiceHypoxia-Inducible Factor 1, alpha SubunitSTAT3 Transcription FactorMembrane ProteinsRNA-Binding ProteinsAdenosineMaleMice, NudeSignal Transduction

Stichwörter der Autor:innen

GlycolysisPDACSTRA6VIRMAm(6)A modification

Substanzen

MethyltransferasesHypoxia-Inducible Factor 1, alpha SubunitSTAT3 Transcription FactorMembrane ProteinsHIF1A protein, humanRNA-Binding ProteinsAdenosineSTAT3 protein, human

Autor:innen und Institutionen

  • Department of Gastroenterology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, PR China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Ho…
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, PR China; Guangdong-Hong Kong Joint Laboratory for RNA Medicine,…
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, PR China; Department of Nephrology, Sun Yat-Sen Memorial Hospital…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, K., Zhong, Z., Zou, J., Liao, J. Y., Chen, S., Zhou, S., Zhao, Y., Li, J., Yin, D., Huang, K., & Li, Y. (2024). Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic ductal adenocarcinoma. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.216840

Vancouver

Yang K, Zhong Z, Zou J, Liao JY, Chen S, Zhou S, et al. Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic ductal adenocarcinoma. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.216840

BibTeX
@article{Yang2024,
  author = {Yang, Kege and Zhong, Ziyi and Zou, Jinmao and Liao, Jian-You and Chen, Shaojie and Zhou, Shurui and Zhao, Yue and Li, Jiajia and Yin, Dong and Huang, Kaihong and Li, Yaqing},
  title = {Glycolysis and tumor progression promoted by the m6A writer VIRMA via m6A-dependent upregulation of STRA6 in pancreatic ductal adenocarcinoma},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.216840}
}
Kostenlos starten →